Tuesday, July 23, 2019
    Latest

    Pharma Watch

    Home Pharma Watch
    Acute Leukemias
    Pharma Watch

    Syndax Pharmaceuticals Announces FDA Clearance of IND for SNDX-5613 for Relapsed/Refractory...

    0
    SMARTvector shRNA Technology
    Pharma Watch

    FDA Approves IND for Celyd’s CAR-T Cell Therapy CYAD-02 Employing Horizon’s...

    0
    Investors Pump $17m into Citryll
    Pharma Watch

    Investors Pump $17m into Citryll, Who is Designing Ways to Stop...

    0
    FDA Places Clinical Hold on Unum Therapeutics Phase 1 Trial Evaluating ACTR087 for RelapsedRefractory CD20+ B cell non-Hodgkin Lymphoma
    Pharma Watch

    FDA Places Clinical Hold on Unum Therapeutics Phase 1 Trial Evaluating...

    0
    BioInvent Receives IND approval from FDA for Phase 12 Trial of Anti-FcγRllB Antibody for Solid Tumors
    Pharma Watch

    BioInvent Receives IND Approval From FDA for Phase 1/2 Trial of...

    0
    Alnylam Submits Marketing Authorization Application to the European Medicines Agency for Givosiran for the treatment of acute hepatic porphyria
    Pharma Watch

    Alnylam Submits Marketing Authorization Application to the European Medicines Agency for...

    0
    Alexion Receives FDA Approval for Soliris for the Treatment of Neuromyelitis Optica Spectrum Disorder in Adults who are AQP4 Antibody Positive
    Pharma Watch

    Alexion Receives FDA Approval for Soliris for the Treatment of Neuromyelitis...

    0
    Karyopharm Receives Accelerated Approval from FDA for Xpovio for Relapsed or Refractory Multiple Myeloma
    Pharma Watch

    Karyopharm Receives Accelerated Approval from FDA for Xpovio for Relapsed or...

    0
    DIABETES CONCEPT
    Pharma Watch

    Belgium-based Imcyse Secures 35M Euros with Type 1 Diabetes Focus

    0
    Philippines Dengue Trial
    Pharma Watch

    Sanofi Pasteur Executives In Philippines Courts Over Implications of Dengvaxia Vaccine...

    0
    123...9Page 1 of 9
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved